CN Patent

CN101203491A — 可用作雄激素受体调节剂的四氢咔唑衍生物（sarm）

Assigned to Eli Lilly and Co · Expires 2008-06-18 · 18y expired

What this patent protects

本发明提供式(I)化合物或其药学可接受的盐；包含有效量的式(I)化合物以及适合的载体、稀释剂或赋形剂的药物组合物；和治疗生理障碍、特别是虚弱、骨质疏松、骨量减少和雄性或雌性性功能障碍的方法，所述方法包括向有需要的患者施用有效量的式(I)化合物。

USPTO Abstract

本发明提供式(I)化合物或其药学可接受的盐；包含有效量的式(I)化合物以及适合的载体、稀释剂或赋形剂的药物组合物；和治疗生理障碍、特别是虚弱、骨质疏松、骨量减少和雄性或雌性性功能障碍的方法，所述方法包括向有需要的患者施用有效量的式(I)化合物。

Drugs covered by this patent

elacestrant-hydrochloride (ELACESTRANT HYDROCHLORIDE)

Patent Metadata

Patent number: CN101203491A
Jurisdiction: CN
Classification: —
Expires: 2008-06-18
Drug substance claim: No
Drug product claim: No
Assignee: Eli Lilly and Co
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.